LCID vs LXRX · rev $687.8M vs rev $21.8M
Lucid Group Inc (LCID) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Silvio Napoli.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported LCID revenue for 2026-06-30 was $687.8M. Net income was -$2.06B. LCID currently screens at market cap $2.04B.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
LCID currently screens at market cap $2.04B. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the LCID and LXRX stock pages for the full models.
Not investment advice.